Get started

Dividend

Altria with mixed feelingsHey everyone, atm i got Altria on the screen with mixed feelings in terms of technical analysis. The green line gives good support while the red box is a huge resistance. The Trend points upwards while the RSI got a divergence. There is also a chance for wave 3 in this current consolidation. You could buy that stock as a dividend position (7,9%) and buy more f the stock goes down. You could also buy with a tight stop included. I will go with the dividend position though. Buy: now / 43.15$ ( Stop: 42.50$ ) Goal: ? Much fun with that trade! Leave a follow please, my goal is 200 :)
NYSE:MO
by QuantinvestGER
NEXO in Aug 2020: Long or ShortIt's rare to find a good cryptocurrency project among hundreds of failed, scam projects. NEXO is one of those, for those who have followed NEXO from first days, it will not be hard to see the possibility of their success in the future. The Crypto Market 2020 seems to be getting back on track. Can Bitcoin break the old peaks or can Ethereum successfully update to version 2.0? All of which can affect to NEXO's price. Technically, the ability of NEXO growth in 2020 is entirely possible, fundamental analysis also supported this. I'm looking at $0.40 in the next 6 months to 1 year. This analysis is for reference only. Not an investment advice. Disclaimer! Good luck guys!
HITBTC:NEXOUSDLong
by StevenPhuHuynh
BAC compared to SPX and NDX: Dot com top and bottomBerkshire Hathaway bought 33.9 million shares of the banking giant between Monday and Wednesday. That increased Berkshire's stake in Bank of America by $813.3 million to more than $24 billion. BRK holds 11.5% of BAC now. BAC chart compared to S&P500. Observe the top of both the NASDAQ and S&P BAC started bottoming when the 2 indices started falling. 2008 was a banking crisis which directly impacted BAC and it fell relatively harder than the indices. In 2020, Banks are well capitalised and backed by the FED, so chances of a banking crisis are slim. Add to that, NASDAQ is clearly overcooked at the moment(Check the historical chart. Top of the major trendline. That said, it Could also break up)
NYSE:BAC
by ashainp
ABBV buy the dip ahead of pharma seasonAbbvie's volume has slackened somewhat after its recent triangle breakout, and it has broken its steep upward trendline. We may see a small correction late this month as Abbvie pulls back toward triangle top. However, if healthcare and pharmaceutical sector earnings continue to deliver this month (as they have so far), then Abbvie should get some buying volume along with the rest of the sector. And then in August, a period of seasonal pharmaceutical strength begins. In The Stock Traders' Almanac, Jeffrey Hirsch makes an extensive study of seasonal stock market performance by sectors. His third-best-performing seasonal trade by average 10-year return (16.8%) is to go long biotech from early August to early March. I believe that's because this is the busy season for FDA drug application reviews. The pharma sector does have an unusual level of political risk this year. Democrats have traditionally been hard on the pharma sector, and they look poised this year for a sweep. If the polls remain strongly blue, then we might see pharma underperform this year. That said, I think a lot of the political risk is already priced in. Whereas most of the stocks I look at are at the very top of their 3-year valuation range in terms of forward earnings and sales, pharmaceutical companies like Abbvie and Merck are trading in the bottom quartile of their 3-year valuation range. With forward PEG ratio around 2, forward PSG ratio around 0.5, and a whopping 5% dividend, Abbvie looks really attractively valued. I've been doing a lot of deal-hunting lately, and this is one of the only stocks I've seen with both a strong growth story and a valuation I really like. The analysts and options traders like it too; Abbvie has a 9.9/10 Equity Starmine Summary Score, and near-dated options positions are heavily skewed toward calls.
NYSE:ABBVLong
by ChristopherCarrollSmith
1
Wrong-way earnings play on Kroger offers opportunity to buyKroger reported blow-out earnings and sales today, handily beating both the Wall Street and Estimize consensuses. The stock is moving down, however, perhaps because this quarter's earnings were a blip and next quarter's earnings are expected to be in a more normal range. I could see the stock selling off over the next month or so as the "Covid-19 bump" goes away. However, some increased demand will remain over the next few quarters as consumers remain too scared to eat at restaurants. Next quarter's estimates are lower than the current quarter, but still quite a bit higher than 2019 YoY. Also, Kroger's increased cash flow this quarter will get reinvested into the business, leading to higher earnings in the future. Based on Zacks estimates of Kroger earnings for 2021, I estimate the stock's fair value at around $37 per share. We've got a support around $31 per share today, but the reality is that we probably will break that support and continue downward toward the volume support at $28.50. And since it's the slow season, I wouldn't even be surprised to see Kroger hit secondary volume support at $25. I will be scaling in as the stock falls, because I think Kroger is an attractive, dividend-paying investment for a recessionary environment.
NYSE:KR
by ChristopherCarrollSmith
6
TSM - 10% Potential by EOY PLUS DividendsIf price breaks above the local high (look at green dotted line), we might have a runner back to ATH. My stop will be a close below the rising trend line and will move accordingly with price. If you found this to be insightful or helpful, please show appreciation by hitting that like button. If you want more ideas I invite you to follow as well! I try to be here for all of my followers with any questions they might have. Feel free to shoot me a DM or comment below to start a conversation!
NYSE:TSMLong
by chartsareforships
Soon 20$ baught at 15.5$, 9%+ dividend.I am a long boy. This is a once in 10 years trade for me. Wish me luck. This is how you dividend invest, unlike youtubers claim. Bull market= grow capital Bear market/crash= one, safe long tearm dividend investment. 10 years this will give me closer to a 15% dividend and compunding. Ill use the dividend to growth invest during bull markets. 1. What i would say is one of the best CEOs and mangers in riet sector. 2. Compunding 25+ -% a year 18% growth 6% div growth. 3. Love that they refuse to take loans to pay dividend. 4. I listen to warren buffets etc while working and some one asked him if he had to chose a company to invest 100% of his money, what company would it be? I found this out after i baught it. Warren named Stor and said that it has one of the best mangments and in 2004 it would have been a great buy or he would have baught Ko. Well guess what i gott it cheaper then 2004. If it drops bellow 15.5 ill invest everything i made from my oil tankers (130% gains currently).
SLong
by epicscoreeu
4
BMY is worth buyingBristol-Myers Squibb says it has seen no major business disruptions and expects no decrease in global demand for its drugs this year. That means the 3.5% dividend yield should stay stable, and BMY is a great value at 1.3 PEG. BMY also just got FDA approval for a multiple sclerosis drug, which could turn out to be a pretty big deal. Most of the market has been trading based on macroeconomics, but as individual companies like BMY issue quantitative guidance, I think we're going to see more trading on company specifics. I bought a small position here and will add the dip if BMY heads south with the rest of the market next week.
NYSE:BMYLong
by ChristopherCarrollSmith
8
Frontline may be able to sustain its 20% dividendI've just learned that oil tanker booking fees are near record highs as oil producers scramble to ship their excess product to available storage locations, which are filling up fast. This suggests that the share price reduction in tanker companies like Frontline may be unwarranted, and they may be able to sustain their dividends in a market in which many dividends are being cut. Frontline's dividend yield is currently over 21%.
NYSE:FROLong
by ChristopherCarrollSmith
7
NBLX may be too cheap to ignore with 50% dividend yieldNoble Midstream Partners has been finding some support in this area as its dividend yield reached 50%. This morning it also has a tailwind from geopolitical conflict in the Middle East that may pressure oil prices in an upward direction in coming months (although of course coronavirus puts price pressure in the opposite direction). Noble also released a press release this morning that offers some reassurance about their financial health. They're reducing their capital expenditures by about $75 million in order to offset lower revenues, and they say they've got more room to cut if necessary. "Noble Midstream anticipates the additional capital savings will essentially offset the cash flow loss from reduced activity." Even if Noble ends up suspending its dividend for the next couple years, this could still be a great long-term buy for a retirement account where you plan to hold it for 30 years.
NLong
by ChristopherCarrollSmith
GBPAUD Second Analysis/Idea Via 1M/ProjectionAnalysis of GBPAUD according to the 1M Chart Timeframe. We can first identify our low for the month, hereafter breaking into an ascending pattern towards our resistance level @1.918339. At our first resistance level we can see our ascending consolidation of patterns broken, allowing price to further surge creating bullish exhaustion towards the upside. If Price is able to extend over our second resistance @2.002689, we can be confident about entering a second BUY position unless price comes back down and breaks our first Resistance level. However if price looks to decline, we will need to verify our second confirmation of price entering a downtrend position and therefore breaking our Resistance 1 before looking to enter a SELL position. Fundamentals: The Australian Dollar hits low considering spike in January unemployment rate from 5.1-5.3%. Reserve Bank of Australia looks to revisit Australian economic outlook dictating additional guidance. Overall rate of GBPAUD has potential to hit May 2016 High depicting AUD weakness.
Long
by adelmourad
First-ever dividend on CURO is bullish long-termI'm uncertain what CURO will do tomorrow after its mixed earnings report, lowish sales guidance, and announcement of a share buyback and first-ever dividend. What I do believe is that the initiation of a dividend will be quite bullish for the stock in the medium-to-long-term. Stocks that initiate a dividend for the first time tend, over the next 6-12 months, to move toward a higher multiple than they've traded at in the past. CURO currently trades at about 7.5 P/E and 3.5 forward P/E, according to data from Fidelity. Its PEG ratio is an extraordinarily low 0.3, making it one of the most undervalued stocks in the entire market. On CURO, I think it's reasonable to expect forward P/E to come up into the 10-15 range, at least, over the next year. That would require roughly tripling the share price from its current extremely undervalued level. The dividend yield, by the way, is a little over 2% at the current price, so you have that to look forward to as well. CURO's share buyback should also help boost the price, and then of course there's the expected 3.5%-10.5% growth of adjusted earnings next year. All in all, I think the signs point toward a strong future for CURO, and I likely will add some January 1 calls to the shares I already own.
CLong
by ChristopherCarrollSmith